Rutgers | GenomeWeb

Rutgers

The agency is funding genome sequencing and analysis centers to research the genomic basis of common diseases, as well as ongoing rare disease research.

A study in Molecular Cell shows CRISPR-Cas9-like genome editing in human cells and suggests one protein could be an RNA-guided, RNA-cleaving endonuclease.

With the award, the Rutgers University's Human Genetics Institute of New Jersey unit will provide pluripotent stem cell derivation and quality control services.

The new workflow, which was validated across three separate laboratories in New Jersey, is a critical step toward standardizing the use of RNA-seq in clinical genomics.

The oncology data warehouse started by the Moffitt Cancer Center and Ohio State University Comprehensive Cancer Center now has nine members.

The award will go to David Alland to create an Ebola test using the same technology as a TB assay marketed by Cepheid.

NEW YORK (GenomeWeb) – A new phylogenomic study has provided the most comprehensive picture of the insect family tree to date, pinning down when and how insect species diverged from one another.

NEW YORK (GenomeWeb) – Rutgers University today said that it has received a $10 million anonymous pledge to the university's foundation to expand genetic-based research into cancer.

NEW YORK (GenomeWeb) — RUCDR Infinite Biologics, the research services and biorepository arm of the Rutgers University Cell and DNA Repository (RUCDR), has been named a RainDance Technologies Center of Excellence, the partners said this week.

NEW YORK (GenomeWeb News) – The BioProcessing Solutions Alliance, a partnership between RUCDR Infinite Biologics at Rutgers University and BioStorage Technologies, has received a five-year contract from the US Department of Veterans Affairs to handle samples, genotyping and analysis, and quality

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.